Detecting When it Matters Most
AI that alerts radiologists to missed findings in real-time
ABOUT US
Vision
The medical world is making huge strides in developing innovative and effective treatments for life-threatening diseases, but in many cases the most influential factor in the chances of recovery is not the quality of the treatment, but how early the disease is diagnosed.
IMedis is on a mission to transform early detection and follow-up care by harnessing the power of AI.
HOW WE CAN HELP
Why IMedis
Our Solution
The IMedis proprietary platform consists of a series of clinically proven deep learning algorithms that analyze medical images and free text, revealing unreported findings but without impacting throughput
BENEFITS
Utilize Every CT for Early-Stage Detection
Studies show that as many as 6% of CT studies have missed findings that require follow-up.
Using our AI-based IMedis-Platform, we can detect and help 10,000 people per-day in the US alone.
Due to time pressure, radiologists are focused on the clinical indication for which a scan is
performed, and are susceptible to miss subtle peripheral findings, resulting in a lost opportunity for early detection of cancer or cardiovascular disease.
Our high-performance algorithms will empower radiologists by helping them detect more early-stage findings and give their patients the medical treatment they need.
Clinical Indications
Thoracic Aorta Dilation*
Pulmonary Nodules*
Liver Lesions*
Abdominal Aorta Dilation*
On our Roadmap
-
Pancreatic Lesions
-
Renal Lesions
-
Mediastinal Lesions
-
Pulmonary Artery Dilation
-
And More…
* Investigational device, limited by United States law to investigational use